20072020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article

Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting

Aluwini, S. S., Mehra, N., Lolkema, M. P., Oprea-Lager, D. E., Yakar, D., Stoevelaar, H., van der Poel, H., Busstra, M., de Jong, I-J., de Reijke, T., de Vries, K., Heijmink, S., Jenster, G., Klaver, S., Kneppers, J., Lavalaye, J., Leyten, G., Moonen, L., Nagaraj, J., Noordzij, W. & 16 others, Osanto, S., Oving, I., Schaake, E., Scheenen, T., Schoots, I., Sedelaar, M., Somford, D., van den Berkmortel, F., van der Hulle, T., van der Voort van Zyp, J., van Leeuwen, P., van Moorselaar, J., van Oort, I., Vogel, W., Westgeest, H. & Dutch Oligometastatic Prostate Cancer Working Group, 2020, In : European Urology Oncology. 3, 2, p. 231-238

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry

Notohardjo, J. C. L., Kuppen, M. C. P., Westgeest, H. M., van Moorselaar, R. J. A., Mehra, N., Coenen, J. L. L. M., van Oort, I. M., de Vos, A. I., Vervenne, W. L., van den Bergh, A. C. M., Aben, K. K. H., Somford, D. M., Bergman, A. M., Uyl-de Groot, C. A., Gerritsen, W. R. & van den Eertwegh, A. J. M., 1 Jan 2020, (Accepted/In press) In : European Urology Focus.

Research output: Contribution to journalArticleAcademicpeer-review

2019

Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?

Jansen, B. H. E., Nieuwenhuijzen, J. A., Oprea-Lager, D. E., Yska, M. J., Lont, A. P., van Moorselaar, R. J. A. & Vis, A. N., 1 Mar 2019, In : Urologic Oncology. 37, 3, p. 181.e1-181.e6

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX)

Bex, A., Van Thienen, J. V., Schrier, M., Graafland, N., Kuusk, T., Hendricksen, K., Lagerveld, B., Zondervan, P., van Moorselaar, J. R. A., Blank, C., Wilgenbos, S. & Haanen, J., 1 Jul 2019, In : Future Oncology. 15, 19, p. 2203-2209 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

A two-gene methylation signature for the diagnosis of bladder cancer in urine

Bosschieter, J., Nieuwenhuijzen, J. A., Hentschel, A., van Splunter, A. P., Segerink, L. I., Vis, A. N., Wilting, S. M., Lissenberg-Witte, B. I., A van Moorselaar, R. J. & Steenbergen, R. D., Feb 2019, In : Epigenomics. 11, 3, p. 337-347 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial

Boevé, L. M. S., Hulshof, M. C. C. M., Vis, A. N., Zwinderman, A. H., Twisk, J. W. R., Witjes, W. P. J., Delaere, K. P. J., Moorselaar, R. J. A. V., Verhagen, P. C. M. S. & van Andel, G., 1 Mar 2019, In : European Urology. 75, 3, p. 410-418 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors

Jansen, H., van Oort, I. M., van Andel, G., Wijsman, B. P., Pos, F. J., Hulshof, M. C. C. M., Hulsbergen-van de Kaa, C. A., van Leenders, G. J. L. H., Fütterer, J. J., Somford, D. M., Busstra, M. B., van Moorselaar, R. J. A., Kiemeney, L. A. & Aben, K. K. H., 2019, In : Prostate Cancer and Prostatic Diseases. 22, 4, p. 337-343

Research output: Contribution to journalArticleAcademicpeer-review

Introducing Decision Aids into Routine Prostate Cancer Care in The Netherlands: Implementation and Patient Evaluations from the Multi-regional JIPPA Initiative

Cuypers, M., Al-Itejawi, H. H. M., van Uden-Kraan, C. F., Stalmeier, P. F. M., Lamers, R. E. D., van Oort, I. M., Somford, D. M., van Moorselaar, R. J. A., Verdonck-de Leeuw, I. M., van de Poll-Franse, L. V., van Tol-Geerdink, J. J. & de Vries, M., 5 Jul 2019, In : Journal of Cancer Education.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Lokale behandeling bij het primair gemetastaseerd prostaatcarcinoom

Translated title of the contribution: Local therapy in primary metastatic prostate cancerBoevé, L. M. S., Hulshof, M. C. C. M., Vis, A. N., de Vries, P., van Moorselaar, R. J. A., Witjes, W. P. J., Verhagen, P. C. M. S. & van Andel, G., 1 Oct 2019, In : Tijdschrift voor Urologie. 9, 6-7, p. 103-107 5 p.

Research output: Contribution to journalArticleProfessional

Open Access

Prostate cancer development is not affected by statin use in patients with elevated psa levels

Meijer, D., van Moorselaar, R. J. A., Vis, A. N. & Bijnsdorp, I. V., 2019, In : Cancers. 11, 7, 953.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry

Kuppen, M. C. P., Westgeest, H. M., van den Eertwegh, A. J. M., van Moorselaar, R. J. A., van Oort, I. M., Coenen, J. L. L. M., van den Bergh, A. C. M. F., Mehra, N., Somford, D. M., Bergman, A. M., Ten Bokkel Huinink, D., Fossion, L., Geenen, M. M., Hendriks, M. P., van de Luijtgaarden, A. C. M., Polee, M. B., Weijl, N. I., van de Wouw, A. J., de Wit, R., Uyl-de Groot, C. A. & 1 others, Gerritsen, W. R., 7 Oct 2019, In : European Urology Oncology.

Research output: Contribution to journalArticleAcademicpeer-review

Renal imaging in 199 Dutch patients with Birt-Hogg-Dubé syndrome: Screening compliance and outcome

Johannesma, P. C., van de Beek, I., van der Wel, T. J. W. T., Reinhard, R., Rozendaal, L., Starink, T. M., van Waesberghe, J. H. T. M., Horenblas, S., Gille, H. J. J. P., Jonker, M. A., Meijers-Heijboer, H. E. J., Postmus, P. E., Houweling, A. C. & van Moorselaar, J. R. A., 1 Mar 2019, In : PLoS ONE. 14, 3, e0212952.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

The Surgical Techniques and Outcomes of Secondary Phalloplasty After Metoidioplasty in Transgender Men: An International, Multi-Center Case Series

Al-Tamimi, M., Pigot, G. L., van der Sluis, W. B., van de Grift, T. C., van Moorselaar, R. J. A., Mullender, M. G., Weigert, R., Buncamper, M. E., Özer, M. J., de Haseth, K. B., Djordjevic, M. L., Salgado, C. J., Belanger, M., Suominen, S., Kolehmainen, M., Santucci, R. A., Crane, C. N., Claes, K. E. Y., Monstrey, S. & Bouman, M-B., 1 Nov 2019, In : Journal of Sexual Medicine. 16, 11, p. 1849-1859 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study

Rijksen, B. L. T., Pos, F. J., Hulshof, M. C. C. M., Vernooij, R. W. M., Jansen, H., van Andel, G., Wijsman, B. P., Somford, D. M., Busstra, M. B., van Moorselaar, R. J. A., Kaa, C. A. H. D., van Leenders, G. J. L. H., Hamberg, P., van den Berkmortel, F., Fütterer, J. J., Kiemeney, L. A., van Oort, I. M. & Aben, K. K. H., 17 Nov 2019, In : European Urology Focus.

Research output: Contribution to journalArticleAcademicpeer-review

A protocol for urine collection and storage prior to DNA methylation analysis

Bosschieter, J., Bach, S., Bijnsdorp, I. V., Segerink, L. I., Rurup, W. F., van Splunter, A. P., Bahce, I., Novianti, P. W., Kazemier, G., van Moorselaar, R. J. A., Steenbergen, R. D. M. & Nieuwenhuijzen, J. A., 2018, In : PLoS ONE. 13, 8, p. e0200906

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands

Westgeest, H. M., Kuppen, M., van den Eertwegh, A. J. M., Van Moorselaar, J., Mehra, N., van Oort, I., van den Bergh, A. C. M., Coenen, J. L., Aben, K. K. H., Somford, R., de Wit, R., Bergman, A., Lavalaye, J., Uyl-de Groot, C. A. & Gerritsen, W. R., 1 Oct 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii283-viii284

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry

Westgeest, H. M., Uyl-de Groot, C. A., van Moorselaar, R. J. A., de Wit, R., van den Bergh, A. C. M., Coenen, J. L. L. M., Beerlage, H. P., Hendriks, M. P., Bos, M. M. E. M., van den Berg, P., van de Wouw, A. J., Spermon, R., Boerma, M. O., Geenen, M. M., Tick, L. W., Polee, M. B., Bloemendal, H. J., Cordia, I., Peters, F. P. J., de Vos, A. I. & 3 others, van den Bosch, J., van den Eertwegh, A. J. M. & Gerritsen, W. R., 1 Sep 2018, In : European Urology Focus. 4, 5, p. 694-701 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Non-muscle-invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors.

Bosschieter, J., Hentschel, AE., Savci - Heijink, CD., van der Voorn, P. J. J. P., Rozendaal, L., Vis, AN., Rhijn, B. W. G., Lissenberg-Witte, BI., van de Putte, E. E. F., van Moorselaar, RJA. & Nieuwenhuijzen, JA., Oct 2018, In : Clinical Genitourinary Cancer. 16, 5, p. e985-e992

Research output: Contribution to journalArticleAcademicpeer-review

Symptomatic skeletal related events (SSE) and SSE-free-survival in real world castration-resistant prostate cancer (CRPC) patients: Results from CAPRI

Kuppen, M., Westgeest, H. M., van den Eertwegh, A. J. M., Van Moorselaar, J., Mehra, N., van Oort, I., van den Bergh, A. C. M., Coenen, J. L., Aben, K. K. H., Somford, R., Lavalaye, J., Bergman, A., Uyl-de Groot, C. A. & Gerritsen, W. R., 1 Oct 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii282-viii283

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review

Bosschieter, J., Lutz, C., Segerink, L. I., Vis, A. N., Zwarthoff, E. C., A van Moorselaar, R. J., van Rhijn, B. W., Heymans, M. W., Jansma, E. P., Steenbergen, R. D. & Nieuwenhuijzen, J. A., May 2018, In : Epigenomics. 10, 5, p. 673-687 15 p.

Research output: Contribution to journalArticleAcademicpeer-review

Re: 10-Year Outcomes After Monitoring, Surgery or Radiotherapy for Localized Prostate Cancer.

van Moorselaar, RJA. & de Reijke, T. M., Sep 2017, In : European Urology.

Research output: Contribution to journalArticleAcademicpeer-review

2016

Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?

Johannesma, P. C., Houweling, A. C., Menko, F., van de Beek, I., Reinhard, R., Gille, J. J. P., van Waesberghe, J., Thunnissen, E., Starink, T. M., Postmus, P. E. & van Moorselaar, R. J. A., Apr 2016, In : Familial Cancer. 15, 2, p. 297-300

Research output: Contribution to journalArticleAcademicpeer-review

Customized Tool for the Validation of Optical Coherence Tomography in Differentiation of Prostate Cancer

Muller, B. G., Swaan, A., de Bruin, D. M., van den Bos, W., Schreurs, A. W., Faber, D. J., Zwartkruis, E. C. H., Rozendaal, L., Vis, A. N., Nieuwenhuijzen, J. A., van Moorselaar, R. J. A., van Leeuwen, T. G. & de la Rosette, J. J. M. C. H., 27 Jan 2016, In : Technology in Cancer Research and Treatment.

Research output: Contribution to journalArticleAcademicpeer-review

Development of a patient decision aid for the treatment of localised prostate cancer: a participatory design approach

Al-Itejawi, H. H. M., van Uden-Kraan, C. F., Vis, A. N., Nieuwenhuijzen, J. A., Hofstee, M. J. A., van Moorselaar, R. J. A. & Verdonck-de Leeuw, I. M., Apr 2016, In : Journal of Clinical Nursing. 25, 7-8, p. 1131-1144

Research output: Contribution to journalArticleAcademicpeer-review

miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110

Bijnsdorp, I. V., Hodzic, J., Lagerweij, T., Westerman, B., Krijgsman, O., Broeke, J., Verweij, F., Nilsson, R. J. A., Rozendaal, L., van Beusechem, V. W., van Moorselaar, J. A., Wurdinger, T. & Geldof, A. A., 29 Mar 2016, In : Oncotarget. 7, 13, p. 16676-16687

Research output: Contribution to journalArticleAcademicpeer-review

Non-invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles

Koppers-Lalic, D., Hackenberg, M., de Menezes, R., Misovic, B., Wachalska, M., Geldof, A., Zini, N., de Reijke, T., Wurdinger, T., Vis, A., van Moorselaar, J., Pegtel, M. & Bijnsdorp, I., 19 Apr 2016, In : Oncotarget. 7, 16, p. 22566-22578

Research output: Contribution to journalArticleAcademicpeer-review

Percutaneous Needle Based Optical Coherence Tomography for the Differentiation of Renal Masses: a Pilot Cohort

Wagstaff, P. G. K., Ingels, A., de Bruin, D. M., Buijs, M., Zondervan, P. J., Heijink, C. D. S., van Delden, O. M., Faber, D. J., van Leeuwen, T. G., van Moorselaar, R. J. A., de la Rosette, J. J. M. C. H. & Pes, M. P. L., May 2016, In : The Journal of Urology. 195, 5, p. 1578-1584

Research output: Contribution to journalArticleAcademicpeer-review

Protein complexes in urine interfere with extracellular vesicle biomarker studies

Wachalska, M., Koppers-Lalic, D., van Eijndhoven, M. A., Pegtel, DM., Geldof, AA., Lipinska, A. D., van Moorselaar, RJA. & Bijnsdorp, IV., 2016, In : Journal of Circulating Biomarkers. p. 1-6

Research output: Contribution to journalArticleAcademic

Should centralized histopathological review in prostate cancer be the gold standard?

Al-Itejawi, HHM., Nieuwenhuijzen, JA., Rozendaal, L., van der Kwast, T. H., van Moorselaar, RJA., van Moorselaar, RJA. & Vis, AN., 2016, In : J Pros Canc. p. 107

Research output: Contribution to journalArticleAcademic

Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project

Postema, A. W., De Reijke, T. M., Ukimura, O., Van den Bos, W., Azzouzi, A. R., Barret, E., Baumunk, D., Blana, A., Bossi, A., Brausi, M., Coleman, J. A., Crouzet, S., Dominguez-Escrig, J., Eggener, S., Ganzer, R., Ghai, S., Gill, I. S., Gupta, R. T., Henkel, T. O., Hohenfellner, M. & 21 others, Jones, J. S., Kahmann, F., Kastner, C., Kohrmann, K. U., Kovacs, G., Miano, R., van Moorselaar, R. J., Mottet, N., Osorio, L., Pieters, B. R., Polascik, T. J., Rastinehad, A. R., Salomon, G., Sanchez-Salas, R., Schostak, M., Sentker, L., Tay, K. J., Varkarakis, I. M., Villers, A., Walz, J. & De la Rosette, J. J., Oct 2016, In : World Journal of Urology. 34, 10, p. 1373-1382

Research output: Contribution to journalArticleAcademicpeer-review

2015

[F-18]Fluoromethylcholine as a Chemotherapy Response Read-Out in Prostate Cancer Cells

Oprea, D., van Kanten, M. P., van Moorselaar, R. J. A., van den Eertwegh, A. J. M., van de Ven, P. M., Bijnsdorp, I. V., Hoekstra, O. S. & Geldof, A. A., 2015, In : Molecular Imaging and Biology. 17, 3, p. 319-327

Research output: Contribution to journalArticleAcademicpeer-review